Global Meningitis Diagnostic Testing Market to Reach $159 Million by 2030
The global market for Meningitis Diagnostic Testing estimated at US$124.8 Million in the year 2023, is expected to reach US$159 Million by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Lateral Flow Assay, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$28.3 Million by the end of the analysis period. Growth in the PCR Assay segment is estimated at 3.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $33.2 Million, While China is Forecast to Grow at 5.3% CAGR
The Meningitis Diagnostic Testing market in the U.S. is estimated at US$33.2 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$32.3 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 2.8% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$20.8 Million by the year 2030.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook